-
-
-
-
-
-
-
BMS presents five-year Camzyos data for heart condition at ESC
-
-
-
-
-
-
-
Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?
-
-
-
-
-
-
-
FDA accepts Bristol Myers Squibb's mezigdomide application for myeloma
-
-
-
-
-
-
-
Bristol Myers Squibb gains EU approval for Opdivo combination in lymphoma
-
-
-
-
-
-
-
Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform Across Its Global Operations
-
-
-
-
-
-
-
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
-
-
-
-
-
-
-
Bristol Myers Squibb Reinforces Leadership in oHCM with New Camzyos (mavacamten) Data at American College of Cardiology Annual Scientific Session & Expo 2026 (ACC.26)
-
1,225,049 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

